- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
Specialises in
- General
- Haemato-oncology
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
Dr Shankara Paneesha MD FRCP FRCPath is a Consultant Haematologist based at The University Hospitals Birmingham NHS Foundation Trust in Birmingham. He also consults at Spire Little Aston and Spire Parkway Hospitals.
Dr Paneesha graduated from Mysore University in 1993 and obtained a postgraduate qualification in General Medicine from Bombay University in 1996. He completed his specialist training in haematology at the West Midlands Deanery, following initial training at the Royal Free and the Royal Marsden Hospitals in London.
Dr Paneesha undertook a period of research in myeloma and venous thrombosis at Warwick University. He has significant experience in the treatment of haematological malignancies including leukaemia, lymphoma and myeloma, and in investigating thrombosis risk factors, inherited thrombophilia and stem cell transplantation.
Dr Paneesha was appointed as a Consultant Haematologist in March 2007 at the Heart of England NHS Foundation Trust. His main interests are malignant haematology, stem cell transplantation and venous thrombosis, and he has published research in top international haematology journals. Dr Paneesha plays a leading role in a large number of trials in haemato-oncology, either as a principal investigator or as co-investigator at his institution.
Areas of interest
Stem cell transplantation; Lymphoproliferative disorders; Immunohaematology; Leukaemia; Lymphoma; Chronic Lymphocytic Leukaemia, Mantle Cell Lymphoma, Follicular lymphoma Deep vein thrombosis (DVT); Haemochromatosis; Myeloma; Haematological oncology; bone marrow transplantation; Thrombosis; general haematology
Medical secretaries
- Amy Price
- 07471 074099
- amy.price2@uhb.nhs.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
Spire Little Aston Hospital (5-50) Spire Parkway Hospital (5-50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
Spire Little Aston Hospital (5-50) Spire Parkway Hospital (5-50)
-
W3650
Diagnostic aspiration and trephine biopsy of bone marrow, including analysis - (1-5)
Spire Parkway Hospital (1-5) Spire Little Aston Hospital (1-5)
-
X0001
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 0-7 days - (1-5)
Spire Parkway Hospital (1-5)
-
L9180
Insertion of implantable central venous port (portacath) e.g Port-a-Cath under image guidance - (1-5)